ES2169804T3 - Actividad despigmentante de la proteina señal aguti y peptidos de la misma. - Google Patents

Actividad despigmentante de la proteina señal aguti y peptidos de la misma.

Info

Publication number
ES2169804T3
ES2169804T3 ES96923379T ES96923379T ES2169804T3 ES 2169804 T3 ES2169804 T3 ES 2169804T3 ES 96923379 T ES96923379 T ES 96923379T ES 96923379 T ES96923379 T ES 96923379T ES 2169804 T3 ES2169804 T3 ES 2169804T3
Authority
ES
Spain
Prior art keywords
peptides
aguti
same
signal protein
depigmenting activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96923379T
Other languages
English (en)
Inventor
Vincent J Hearing Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2169804T3 publication Critical patent/ES2169804T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA INVENCION ES UNA PROTEINA DE SEÑALIZACION DE AGOUTI Y PEPTIDOS Y COMPOSICIONES FARMACEUTICAS SIMILARES Y SU EMPLEO EN METODOS DE INHIBICION DE LA PRODUCCION DE MELANINA POR LOS MELANOCITOS. LA PROTEINA DE SEÑALIZACION DE AGOUTI Y PEPTIDOS SIMILARES SON UTILES EN COSMETICA Y PARA LA PREVENCION Y TRATAMIENTO CLINICO DE ENFERMEDADES HIPERPIGMENTARIAS. TAMBIEN SE PROPORCIONAN METODOS DE DETECCION DE PEPTIDOS CON ACTIVIDAD INHIBIDORA DE LA MELANOGENESIS.
ES96923379T 1995-06-23 1996-06-21 Actividad despigmentante de la proteina señal aguti y peptidos de la misma. Expired - Lifetime ES2169804T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43695P 1995-06-23 1995-06-23
AU39381/00A AU747814B2 (en) 1995-06-23 2000-06-08 Depigmenting activity of agouti signal protein and peptides thereof

Publications (1)

Publication Number Publication Date
ES2169804T3 true ES2169804T3 (es) 2002-07-16

Family

ID=25624757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96923379T Expired - Lifetime ES2169804T3 (es) 1995-06-23 1996-06-21 Actividad despigmentante de la proteina señal aguti y peptidos de la misma.

Country Status (6)

Country Link
EP (1) EP0833843B1 (es)
JP (1) JPH11508263A (es)
AU (2) AU716849B2 (es)
CA (1) CA2224691A1 (es)
ES (1) ES2169804T3 (es)
WO (1) WO1997000892A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843652A (en) * 1993-05-21 1998-12-01 Lockheed Martin Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
EP0988379B1 (en) * 1997-04-15 2007-04-11 The Wellcome Trust Limited as Trustee to the Wellcome Trust Ldl-receptor
ID26632A (id) * 1998-05-06 2001-01-25 Galderma Res & Dev Pengujian terhadap identifikasi senyawa yang mengangkat produksi melamin dan retinoid seperti senyawa yang didentifikasi tersebut
US7498310B1 (en) * 1998-08-13 2009-03-03 Beiersdorf Ag Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
US6296857B1 (en) * 1998-09-23 2001-10-02 Beiersdorf Aktiengesellschaft Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
EP1093804A1 (en) * 1999-10-19 2001-04-25 Beiersdorf Aktiengesellschaft Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin
US20030129259A1 (en) * 2001-12-28 2003-07-10 Avon Products, Inc. Topical lightening compostitions and methods of use
DE10238449A1 (de) * 2002-08-22 2004-03-04 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitung

Also Published As

Publication number Publication date
WO1997000892A2 (en) 1997-01-09
AU3938100A (en) 2000-08-17
EP0833843B1 (en) 2002-01-02
EP0833843A2 (en) 1998-04-08
WO1997000892A3 (en) 1997-03-20
CA2224691A1 (en) 1997-01-09
AU6390496A (en) 1997-01-22
AU716849B2 (en) 2000-03-09
JPH11508263A (ja) 1999-07-21
AU747814B2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
BR9607318A (pt) Peptidos e composição farmacêutica
DE69632756D1 (de) Hautpflegemittel
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
IS4644A (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO982809L (no) Prolegemidler av tombin-inhibitorer
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
PT871656E (pt) Derivados de dolastatina sua preparacao e utilizacao
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
BR9609831A (pt) Composições cosméticas e/ou farmacêuticas antipruríticas
DE69516453D1 (de) Hautpflegemittel
ES2169804T3 (es) Actividad despigmentante de la proteina señal aguti y peptidos de la misma.
KR970000228A (ko) S-에토돌락의 경구용 제제
BR9601133A (pt) Produto de fibra
NO980296D0 (no) Forbedrede terapeutiske midler
NO973455D0 (no) Dermatologisk anvendelse av Vitamin-D-derivater
FR2735983B1 (fr) Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
BR9510222A (pt) Fabricação de talharim
FI962603A (fi) Hydroksihapon tai sitä sisältävän tuotteen käyttö sekä siitä tehty valmiste
BR9605972A (pt) Composição de xampu
FR2755010B1 (fr) Produit de soins buccaux
ATE276272T1 (de) Entzündungshemmende peptide
IT1277338B1 (it) Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
BR9606455A (pt) Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário
KR970000226A (ko) S-이부프로펜의 경구용 제형

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 833843

Country of ref document: ES